European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 39-43 , February 2007

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

  • H. Kreis

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • C.R. Loehberg

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • M.P. Lux

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • S. Ackermann

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • W. Lang

      Affiliations

    • Department of General Surgery, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • M.W. Beckmann

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • ,
  • P.A. Fasching

      Affiliations

    • Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitaetsstrasse 21–23, D-91054 Erlangen, Bavara, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 9131 853 3508; fax: +49 9131 853 3938.

,Accepted 7 August 2006.

References 

  1. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92:706–712
  2. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12–16
  3. Beckmann MW, Lorenz C, Dall P. Platzierung und Pflege von venösen Verweilkathetern und Portsystemen. Gynaekologe. 2000;33:255–260
  4. Biffi R, Martinelli G, Pozzi S, et al. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant. 1999;24:89–93
  5. Champault G. Totally implantable catheters for cancer chemotherapy: French experience on 325 cases. Cancer Drug Deliv. 1986;3:131–137
  6. Bow EJ, Kilpatrick MG, Clinch JJ. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol. 1999;17:1267
  7. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 2003;21:3357–3365
  8. Borst CG, de Kruif AT, van Dam FS, de Graaf PW. Totally implantable venous access ports–the patients’ point of view. A quality control study. Cancer Nurs. 1992;15:378–381
  9. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136:602–606
  10. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148:871–875
  11. Holloway RW, Orr JW. An evaluation of Groshong central venous catheters on a gynecologic oncology service. Gynecol Oncol. 1995;56:211–217
  12. Basford TJ, Poenaru D, Silva M. Comparison of delayed complications of central venous catheters placed surgically or radiologically in pediatric oncology patients. J Pediatr Surg. 2003;38:788–792
  13. Schwarz RE, Coit DG, Groeger JS. Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol. 2000;7:441–449
  14. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer. 1997;79:1635–1640
  15. Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg. 2001;136:1050–1053
  16. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665–3675
  17. Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol. 2002;3:684–692
  18. Hartkamp A, van Boxtel AJ, Zonnenberg BA, Witteveen PO. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med. 2000;57:215–223

PII: S0748-7983(06)00299-X

doi: 10.1016/j.ejso.2006.08.003

European Journal of Surgical Oncology
Volume 33, Issue 1 , Pages 39-43 , February 2007

Article Tools

* Image Usage & Resolution